NCT07756515 Chatbot Implementation In The Clinical Informed Consent Process
| NCT ID | NCT07756515 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Informed Consent |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-09-11 |
| Primary Completion | 2028-12-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-09-11 with a primary completion date of 2028-12-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.
Eligibility Criteria
Inclusion Criteria: * Ability to understand and willingness to provide informed consent. * Age ≥18 years. * Patients whose preferred language is English. * Patients who are being considered for enrollment in selected clinical research studies. Phase I will be initiated using the Clearinghouse protocol PA11-0852, a non-interventional biomarker study. Exclusion Criteria: N/A
Contact & Investigator
Funda Meric-Bernstam, MD
PRINCIPAL INVESTIGATOR
UT MD Anderson
Frequently Asked Questions
Who can join the NCT07756515 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Informed Consent. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07756515 currently recruiting?
Yes, NCT07756515 is actively recruiting participants. Contact the research team at fmeric@mdanderson.org for enrollment information.
Where is the NCT07756515 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07756515 clinical trial?
NCT07756515 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Funda Meric-Bernstam, MD at UT MD Anderson. The trial plans to enroll 100 participants.